- Home
- IP vs LH Comparison
IP vs LH Comparison
Compare IP & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IP | LH |
|---|---|---|
| Founded | 1898 | 1971 |
| Country | United States | United States |
| Employees | 62602 | 70000 |
| Industry | Paper | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 21.7B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | IP | LH |
|---|---|---|
| Price | $32.03 | $255.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $45.67 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 6.8M | 578.3K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.51% | 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 10.46 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $7.98 | $8.26 |
| Revenue Next Year | $3.53 | $4.81 |
| P/E Ratio | ★ N/A | $24.44 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $29.45 | $239.75 |
| 52 Week High | $56.13 | $293.72 |
Technical Indicators
Market Signals| Indicator | IP | LH |
|---|---|---|
| Relative Strength Index (RSI) | 37.76 | 35.84 |
| Support Level | N/A | $246.08 |
| Resistance Level | $38.04 | $275.06 |
| Average True Range (ATR) | 1.50 | 7.20 |
| MACD | -0.26 | -1.34 |
| Stochastic Oscillator | 29.97 | 11.56 |
Price Performance
Historical ComparisonAbout IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.